SYBR Green PCR is Cost-Effective for Detecting Genetic Abnormalities in Acute Myeloid Leukemia
Keywords:
SYBR Green based RT-PCR, acute myeloid leukemiaAbstract
Objective: To determine whether SYBR Green PCR is cost-effective for detecting genetic abnormalities in acute myeloid Leukemia or not.
Methodology: This cross-sectional study was conducted at Department of Pathology-CMH Lahore medical college and institute of dentistry from October 2023- March 2024. DNA samples from 70 adults diagnosed as AML at various hospitals were ran on RT-PCR using dye and probe-based methods for detection of genetic abnormalities in acute myeloid leukemia (AML). Data was analyzed by SPSS 23 and presented in frequencies and percentages.
Results: In a total of 70 patients, twenty-five (17.5%) had defining genetic abnormalities. Fusions were detected in 19 (13.3%) patients while three rearrangements (2.1%) and three mutations (2.1%) were detected. The probe-based RT-PCR matched results in all patients.
Conclusion: SYBR Green PCR is very cost-effective for detecting genetic abnormalities in acute myeloid leukemia.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Journal of Haematology and Stem Cell Research

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The licensor permits others to copy, distribute, display, and perform the work, as well as make and distribute derivative works based on it. The licensor permits others to copy, distribute, display, and perform the work for non-commercial purposes only.